A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 1,166,705 shares of LLY stock, worth $879 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
1,166,705
Previous 1,080,233 8.0%
Holding current value
$879 Million
Previous $978 Million 5.69%
% of portfolio
1.12%
Previous 1.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $66.8 Million - $83 Million
86,472 Added 8.0%
1,166,705 $1.03 Billion
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $89.6 Million - $112 Million
123,608 Added 12.92%
1,080,233 $978 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $96.9 Million - $130 Million
163,578 Added 20.63%
956,625 $744 Million
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $26 Million - $30.7 Million
49,539 Added 6.66%
793,047 $462 Million
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $20 Million - $27.6 Million
46,021 Added 6.6%
743,508 $399 Million
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $17.1 Million - $22.9 Million
48,752 Added 7.51%
697,487 $327 Million
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $18.8 Million - $22.1 Million
60,509 Added 10.29%
648,735 $223 Million
Q4 2022

Feb 07, 2023

BUY
$321.55 - $374.67 $21.1 Million - $24.6 Million
65,740 Added 12.58%
588,226 $215 Million
Q3 2022

Nov 01, 2022

BUY
$296.48 - $337.87 $13.6 Million - $15.5 Million
45,902 Added 9.63%
522,486 $169 Million
Q2 2022

Aug 04, 2022

BUY
$278.73 - $327.27 $9.65 Million - $11.3 Million
34,610 Added 7.83%
476,584 $155 Million
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $9.32 Million - $11.6 Million
39,726 Added 9.88%
441,974 $127 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $13 Million - $16.1 Million
57,854 Added 16.8%
402,248 $109 Million
Q3 2021

Nov 04, 2021

BUY
$221.6 - $272.71 $6.28 Million - $7.73 Million
28,334 Added 8.96%
344,394 $79.6 Million
Q2 2021

Aug 06, 2021

BUY
$180.55 - $233.54 $5.06 Million - $6.54 Million
28,019 Added 9.73%
316,060 $72.5 Million
Q1 2021

May 06, 2021

BUY
$164.32 - $212.72 $4.92 Million - $6.36 Million
29,917 Added 11.59%
288,041 $53.8 Million
Q4 2020

Feb 09, 2021

BUY
$130.46 - $172.63 $1.25 Million - $1.65 Million
9,552 Added 3.84%
258,124 $43.6 Million
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $4.23 Million - $4.9 Million
28,962 Added 13.19%
248,572 $36.8 Million
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $2.52 Million - $3.03 Million
18,472 Added 9.18%
219,610 $36.1 Million
Q1 2020

May 11, 2020

SELL
$119.05 - $147.35 $1.16 Million - $1.44 Million
-9,761 Reduced 4.63%
201,138 $27.9 Million
Q4 2019

Feb 05, 2020

BUY
$106.92 - $132.43 $2.12 Million - $2.63 Million
19,822 Added 10.37%
210,899 $27.8 Million
Q3 2019

Nov 12, 2019

BUY
$106.79 - $116.16 $17,193 - $18,701
161 Added 0.08%
191,077 $21.4 Million
Q2 2019

Aug 08, 2019

BUY
$110.79 - $129.32 $2.87 Million - $3.35 Million
25,901 Added 15.7%
190,916 $21.2 Million
Q1 2019

Apr 26, 2019

SELL
$111.31 - $131.02 $429,211 - $505,213
-3,856 Reduced 2.28%
165,015 $21.4 Million
Q4 2018

Feb 08, 2019

SELL
$105.9 - $118.64 $2.09 Million - $2.34 Million
-19,704 Reduced 10.45%
168,871 $18.8 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $788,280 - $985,213
-9,181 Reduced 4.64%
188,575 $20.2 Million
Q2 2018

Aug 09, 2018

BUY
$75.7 - $86.88 $223,617 - $256,643
2,954 Added 1.52%
197,756 $16.9 Million
Q1 2018

May 02, 2018

SELL
$74.21 - $87.6 $3 Million - $3.54 Million
-40,455 Reduced 17.2%
194,802 $15.1 Million
Q4 2017

Feb 06, 2018

SELL
$81.94 - $87.89 $146,099 - $156,707
-1,783 Reduced 0.75%
235,257 $20 Million
Q3 2017

Nov 01, 2017

BUY
$77.07 - $85.54 $18.3 Million - $20.3 Million
237,040
237,040 $20.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.